Improving the CellSearch® system
Open Access
- 17 November 2016
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Molecular Diagnostics
- Vol. 16 (12) , 1291-1305
Abstract
Introduction: The CellSearch® CTC test enumerates tumor cells present in 7.5 ml blood of cancer patients. improvements, extensions and different utilities of the cellsearch system are discussed in this paper. Areas c overed: This paper describes work performed with the CellSearch system, which go beyond the normal scope of the test. All results from searches with the search term ‘CellSearch’ from Web of Science and PubMed were categorized and discussed. Expert commentary: The CellSearch Circulating Tumor Cell test captures and identifies tumor cells in blood that are associated with poor clinical outcome. How to best use CTC in clinical practice is being explored in many clinical trials. The ability to extract information from the CTC to guide therapy will expand the potential clinical utility of CTC.Keywords
Funding Information
- Innovative Medicine Initiative (IMI) (IMI grant n° 115749 (CANCER-ID))
- Seventh Framework Programme (2012.1.2-1 #305341)
This publication has 125 references indexed in Scilit:
- Detection of cancer before distant metastasisBMC Cancer, 2013
- Detection of circulating tumor cells in advanced head and neck cancer using the cellsearch systemHead & Neck, 2011
- Circulating tumor cells predict progression free survival and overall survival in patients with relapsed/recurrent advanced ovarian cancerGynecologic Oncology, 2011
- External quality assurance of circulating tumor cell enumeration using the CellSearch® system: A feasibility studyCytometry Part B: Clinical Cytometry, 2010
- HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective, multicenter trialBreast Cancer Research and Treatment, 2010
- All circulating EpCAM+CK+CD45- objects predict overall survival in castration-resistant prostate cancerAnnals of Oncology, 2010
- Characterization of circulating tumor cells by fluorescence in situ hybridizationCytometry Part A, 2009
- Presence of bone marrow micrometastasis is associated with different recurrence risk within molecular subtypes of breast cancerMolecular Oncology, 2007
- uPAR and HER-2 gene status in individual breast cancer cells from blood and tissuesProceedings of the National Academy of Sciences, 2006
- Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast CancerNew England Journal of Medicine, 2004